Blood Pressure Monitoring for Kidney Failure

Palo Alto (17 mi)

Age: 18+

Sex: Any

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: N/A

Waitlist Available

Sponsor: The Rogosin Institute

No Placebo Group

Trial Summary

What is the purpose of this trial?Prospective, single center, open label, non-randomized, post-market study of the Tablo Hemodialysis System and VitalStream Monitor in participants with End-Stage KidneyDisease undergoing In-Center Hemodialysis.

Eligibility Criteria

This trial is for adults over 18 with end-stage kidney disease who are on maintenance dialysis and weigh at least 34kg. They must be able to give informed consent and sign a privacy agreement. It's not suitable for those whose arms can't fit the blood pressure cuffs or have poor blood flow in their lower arm and hand.

Inclusion Criteria

I am over 18, have given my consent, and signed a HIPAA form.

I weigh at least 34kg.

I have advanced kidney disease and am on regular dialysis.

Exclusion Criteria

My hands and lower arms have poor blood flow.

Treatment Details

The study is evaluating how well two types of non-invasive blood pressure monitors work during dialysis: one that measures continuously and another that measures intermittently, using the Tablo Hemodialysis System alongside the VitalStream Monitor.

1Treatment groups

Experimental Treatment

Group I: Non-Invasive Blood Pressure (NIPB)MonitorsExperimental Treatment1 Intervention

NIPB Tablo Brachial Cuff (Intermittent): Will be placed contralateral to the access arm. Blood pressure measurements will be collected pre-dialysis, every 30minutes during dialysis, and post-dialysis. VitalStream Monitor (Continuous):A cuff will be applied to the middlefinger ipsilateral to the accessarm. Blood pressuremeasurements will be collectedpre-dialysis, continuously duringdialysis, and post-dialysis.